Regarding the ban imposed on the export of essential raw materials by America, Serum Institute of India Chief Executive Officer (CEO) Adar Poonawalla said, 'On the export of raw materials Temporary US restrictions may limit production of the Coronavirus Vaccine. Not only this, the increase in global availability of vaccine can also have a serious impact due to the ban on exports'.
Poonawalla also emphasized regulatory coordination between organizations such as the World Health Organization (WHO) and officials in vaccine manufacturer countries such as India, the US, Europe and the UK. He said that both need to come to a common platform and give equal approval to the vaccine.
America implemented Defense Act
Adar Poonawala said, 'Vaccine manufacturers need bags, filters and other essentials. We are the major manufacturers of Novavax Vaccine. We need these goods from America. Now the US has implemented the Defense Act. Which prevents them from exporting the important material that their local manufacturers need.
'Need to talk to Joe Biden administration on this issue'
Addressing a program organized by the World Bank, Poonawala said that there is a need to remove this blockage. This hindrance is of course the availability of goods from America. He said that there is a need to talk to Joe Biden's administration on this issue.